Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: Results from a global multi-site chart review.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: XiangLin Tan, Ryan J. Sullivan, Kavita Gandhi Morar, Alicia Delibes, Ignacio Méndez, Ruixuan Jiang, Clemens Krepler, Elizabeth Mary Gaughan, Aparna Dodla Rao, James Isaacs, Marcin Radoslaw Dzienis, Maria L. Wei, Xiaochen Zhong, Alexandra So, Miso Kim, Yu Jung Kim, Ryan Michael Weight, Nawab Qizilbash, Irene M. Shui
Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Massachusetts General Hospital, University of Virginia, Peter MacCallum Cancer Centre, Cleveland Clinic, Gold Coast Hospital, University of California, San Francisco, Seoul National University, Seoul National University Hospital, Seoul National University Bundang Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Merck
OpenAlex ID: W4410818702